Dublin, Ireland

Peter McGuirk

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Dublin, IE (2013 - 2014)
  • Clonee, IE (2016)

Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Peter McGuirk in Renal Disease Treatment

Introduction

Peter McGuirk is an accomplished inventor based in Dublin, Ireland, known for his significant contributions to the field of medical innovations. With a total of three patents to his name, he has been instrumental in advancing treatments for renal disease and related conditions. His work primarily focuses on developing compounds that improve patient outcomes in complex health scenarios.

Latest Patents

Among his latest patents, McGuirk has made notable strides in the treatment of renal disease. One of his innovative inventions involves compounds and methods aimed at the treatment and prophylaxis of renal disease and inflammation. Specifically, this invention provides methodologies for addressing kidney disease and failure through the administration of compounds that inhibit Toll-Like Receptor 2 (TLR2) function and expression.

In addition, he has developed a composition and method for treating reperfusion injury and tissue damage. This invention focuses on compounds designed to suppress the biological function or expression of TLR2, thereby providing a potential therapeutic avenue for ischemia reperfusion injury.

Career Highlights

Peter McGuirk currently works with Opsona Therapeutics Limited, a pharmaceutical company dedicated to developing innovative therapies. His focus on kidney disease and related inflammation reflects a commitment to tackling pressing health challenges with novel solutions. His patents are a testament to his creative approach in the domain of medical research.

Collaborations

Throughout his career, McGuirk has collaborated with notable colleagues such as Mark Heffernan and Luke O'Neill. These partnerships have fostered an environment of innovation within Opsona Therapeutics Limited, allowing for the exploration of new therapeutic possibilities that harness the power of inventive science.

Conclusion

In summary, Peter McGuirk stands out as a significant figure in the realm of biomedical innovation. His patents and work at Opsona Therapeutics Limited underscore his dedication to improving treatment methodologies for renal disease. As medical challenges evolve, contributions from inventors like McGuirk are vital to advancing healthcare solutions that can change lives.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…